Granisetron Transdermal Patch System for Prevention of CINV by CapeOX
NCT05325190
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
57
Enrollment
OTHER
Sponsor class
Conditions
Chemotherapy-induced Nausea and Vomiting
Interventions
DRUG:
Granisetron Transdermal Patch System
Sponsor
Tianjin Medical University Cancer Institute and Hospital